Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 22 | 2024 | 3223 | 3.150 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 4 | 2023 | 499 | 1.400 |
Why?
|
| Lung Diseases, Interstitial | 4 | 2023 | 907 | 0.780 |
Why?
|
| Pulmonary Emphysema | 2 | 2024 | 688 | 0.650 |
Why?
|
| Respiratory Tract Diseases | 1 | 2024 | 747 | 0.640 |
Why?
|
| Genome-Wide Association Study | 9 | 2024 | 12602 | 0.600 |
Why?
|
| Heparin | 3 | 2021 | 1655 | 0.580 |
Why?
|
| Genetic Markers | 2 | 2022 | 2608 | 0.510 |
Why?
|
| Spirometry | 6 | 2024 | 924 | 0.490 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2024 | 17766 | 0.480 |
Why?
|
| Lung | 12 | 2023 | 9989 | 0.450 |
Why?
|
| Mortality | 1 | 2024 | 2916 | 0.430 |
Why?
|
| Vital Capacity | 4 | 2024 | 965 | 0.410 |
Why?
|
| Smoking | 4 | 2024 | 9070 | 0.390 |
Why?
|
| Asthma | 4 | 2023 | 6167 | 0.380 |
Why?
|
| Respiratory Function Tests | 5 | 2023 | 1684 | 0.380 |
Why?
|
| Venous Thromboembolism | 2 | 2021 | 1866 | 0.370 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 1293 | 0.370 |
Why?
|
| Multifactorial Inheritance | 3 | 2024 | 1351 | 0.360 |
Why?
|
| Forced Expiratory Volume | 4 | 2024 | 1810 | 0.350 |
Why?
|
| Intensive Care Units | 2 | 2021 | 3737 | 0.350 |
Why?
|
| Disease Progression | 3 | 2023 | 13505 | 0.320 |
Why?
|
| Mucin-5B | 3 | 2023 | 147 | 0.310 |
Why?
|
| Hypertension, Pulmonary | 4 | 2021 | 1570 | 0.290 |
Why?
|
| Arthritis, Rheumatoid | 4 | 2024 | 3763 | 0.290 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 2544 | 0.280 |
Why?
|
| Phenotype | 8 | 2024 | 16543 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2023 | 15766 | 0.270 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3086 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3206 | 0.260 |
Why?
|
| Risk Factors | 13 | 2024 | 74269 | 0.240 |
Why?
|
| Inflammation | 2 | 2023 | 10757 | 0.230 |
Why?
|
| Antihypertensive Agents | 3 | 2020 | 2063 | 0.220 |
Why?
|
| Humans | 51 | 2024 | 760261 | 0.210 |
Why?
|
| Anticoagulants | 4 | 2021 | 4896 | 0.200 |
Why?
|
| Pulmonary Artery | 2 | 2020 | 1919 | 0.190 |
Why?
|
| Respiratory System Abnormalities | 1 | 2022 | 67 | 0.190 |
Why?
|
| Emphysema | 1 | 2024 | 240 | 0.190 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2022 | 169 | 0.190 |
Why?
|
| Risk Assessment | 2 | 2022 | 24086 | 0.190 |
Why?
|
| Mitochondria, Liver | 1 | 2021 | 190 | 0.190 |
Why?
|
| Drug Repositioning | 1 | 2023 | 231 | 0.180 |
Why?
|
| Acetyltransferases | 1 | 2021 | 231 | 0.180 |
Why?
|
| Prothrombin Time | 1 | 2020 | 116 | 0.180 |
Why?
|
| Partial Thromboplastin Time | 1 | 2020 | 206 | 0.170 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 15740 | 0.160 |
Why?
|
| Epoprostenol | 1 | 2020 | 248 | 0.160 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2020 | 412 | 0.160 |
Why?
|
| Middle Aged | 18 | 2024 | 220175 | 0.160 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2021 | 141 | 0.160 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2023 | 565 | 0.160 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 418 | 0.150 |
Why?
|
| Enoxaparin | 1 | 2020 | 397 | 0.150 |
Why?
|
| Ferritins | 1 | 2020 | 598 | 0.140 |
Why?
|
| Internationality | 1 | 2022 | 1005 | 0.140 |
Why?
|
| Fibrinogen | 1 | 2020 | 887 | 0.140 |
Why?
|
| Proteomics | 3 | 2024 | 3810 | 0.140 |
Why?
|
| Sebaceous Glands | 1 | 2016 | 42 | 0.130 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 15827 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 1375 | 0.130 |
Why?
|
| Models, Genetic | 2 | 2024 | 3442 | 0.130 |
Why?
|
| Odds Ratio | 3 | 2022 | 9712 | 0.130 |
Why?
|
| Blood Coagulation | 1 | 2021 | 1156 | 0.120 |
Why?
|
| Heterozygote | 1 | 2022 | 2797 | 0.120 |
Why?
|
| Interleukin-10 | 1 | 2020 | 1174 | 0.120 |
Why?
|
| Acetamides | 1 | 2016 | 256 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2020 | 520 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2022 | 15273 | 0.120 |
Why?
|
| Male | 20 | 2024 | 359413 | 0.120 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 281 | 0.120 |
Why?
|
| Female | 21 | 2024 | 391011 | 0.120 |
Why?
|
| Pandemics | 4 | 2022 | 8621 | 0.110 |
Why?
|
| Antirheumatic Agents | 1 | 2023 | 1374 | 0.110 |
Why?
|
| Cause of Death | 2 | 2024 | 3723 | 0.110 |
Why?
|
| Drugs, Investigational | 1 | 2015 | 214 | 0.110 |
Why?
|
| Propensity Score | 1 | 2021 | 1918 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2022 | 11902 | 0.110 |
Why?
|
| Amides | 1 | 2016 | 448 | 0.110 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2016 | 345 | 0.110 |
Why?
|
| Aged | 11 | 2024 | 168995 | 0.100 |
Why?
|
| Adult | 13 | 2024 | 219847 | 0.090 |
Why?
|
| Genotype | 2 | 2023 | 12959 | 0.090 |
Why?
|
| Pyrazines | 1 | 2016 | 1200 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2022 | 20484 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3207 | 0.090 |
Why?
|
| Genetic Variation | 2 | 2022 | 6540 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 1381 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2022 | 41317 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2022 | 4012 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3822 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2024 | 8523 | 0.080 |
Why?
|
| Critical Care | 1 | 2021 | 2699 | 0.080 |
Why?
|
| Critical Illness | 1 | 2021 | 2709 | 0.070 |
Why?
|
| Plastids | 1 | 2007 | 8 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2024 | 54263 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2020 | 5960 | 0.070 |
Why?
|
| Seeds | 1 | 2007 | 116 | 0.070 |
Why?
|
| Postprandial Period | 1 | 2009 | 315 | 0.070 |
Why?
|
| Pneumonia | 1 | 2018 | 2138 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2024 | 12901 | 0.070 |
Why?
|
| Plant Oils | 1 | 2007 | 197 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2022 | 22041 | 0.070 |
Why?
|
| Child | 3 | 2023 | 79758 | 0.060 |
Why?
|
| Pyruvate Kinase | 1 | 2007 | 190 | 0.060 |
Why?
|
| Incidence | 2 | 2020 | 21378 | 0.060 |
Why?
|
| Pyridines | 1 | 2016 | 2877 | 0.060 |
Why?
|
| Arabidopsis | 1 | 2007 | 464 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2022 | 2003 | 0.060 |
Why?
|
| Genetic Loci | 2 | 2022 | 2618 | 0.050 |
Why?
|
| Myostatin | 1 | 2023 | 127 | 0.050 |
Why?
|
| Logistic Models | 3 | 2022 | 13311 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2022 | 12100 | 0.050 |
Why?
|
| Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
| Triglycerides | 1 | 2009 | 2476 | 0.050 |
Why?
|
| Linear Models | 2 | 2021 | 5876 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 289 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 323 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2022 | 469 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5248 | 0.040 |
Why?
|
| Sample Size | 1 | 2022 | 840 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2020 | 64947 | 0.040 |
Why?
|
| Mucin-1 | 1 | 2023 | 539 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 12532 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2020 | 837 | 0.040 |
Why?
|
| Vascular Resistance | 1 | 2020 | 932 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14482 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 1723 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 776 | 0.030 |
Why?
|
| Europe | 1 | 2022 | 3433 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 25928 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 80301 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 9388 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 13249 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2009 | 6562 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 961 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2015 | 592 | 0.030 |
Why?
|
| Monocytes | 1 | 2022 | 2574 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 2716 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 58947 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 1346 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2022 | 5784 | 0.020 |
Why?
|
| Eosinophils | 1 | 2016 | 946 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2021 | 4169 | 0.020 |
Why?
|
| Drug Design | 1 | 2015 | 1062 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10434 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 1493 | 0.020 |
Why?
|
| United States | 3 | 2022 | 72363 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2022 | 6210 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2022 | 10185 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 40133 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2016 | 4044 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7592 | 0.020 |
Why?
|
| Cotyledon | 1 | 2007 | 4 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 4168 | 0.020 |
Why?
|
| Genes, Plant | 1 | 2007 | 128 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12156 | 0.020 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2007 | 212 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15687 | 0.020 |
Why?
|
| Vitamin D | 1 | 2020 | 3293 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2020 | 9283 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2805 | 0.010 |
Why?
|
| Hypertension | 1 | 2024 | 8595 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2007 | 1993 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 666 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2007 | 943 | 0.010 |
Why?
|
| Carbon | 1 | 2007 | 669 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4355 | 0.010 |
Why?
|
| Glycolysis | 1 | 2007 | 828 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2007 | 1792 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 1455 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 26912 | 0.010 |
Why?
|
| Animals | 3 | 2022 | 167940 | 0.010 |
Why?
|
| Protein Transport | 1 | 2007 | 1966 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2009 | 1992 | 0.010 |
Why?
|
| Adolescent | 2 | 2022 | 87747 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29636 | 0.010 |
Why?
|
| Kinetics | 1 | 2007 | 6378 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10340 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 2731 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2007 | 1902 | 0.010 |
Why?
|
| Quality of Life | 1 | 2020 | 13300 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6543 | 0.010 |
Why?
|
| Young Adult | 1 | 2022 | 58673 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 9336 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81216 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 23363 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 8945 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 29950 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 36247 | 0.000 |
Why?
|
Concepts
(189)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(106)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_